Target product profile (TPP) for chagas disease point-of-care diagnosis and assessment of response to treatment

PLoS Neglected Tropical Diseases

Volumn 9, Issue 6, 2015, Pages

  Porrás, Analía I ^a   Yadon, Zaida E ^a   Altcheh, Jaime ^b   Britto, Constança ^c   Chaves, Gabriela C ^c   Flevaud, Laurence ^d   Martins Filho, Olindo Assis ^c   Ribeiro, Isabela ^e   Schijman, Alejandro G ^f   Shikanai Yasuda, Maria Aparecida ^g   Sosa Estani, Sergio ^h   Stobbaerts, Eric ^e   Zicker, Fabio ^c  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d MÉDECINS SANS FRONTIÈRES   (Switzerland)

^e Drugs for Neglected Diseases initiative DNDi   (Brazil)

^f INSTITUTO DE INVESTIGACIONES EN INGENIERÍA GENÉTICA Y BIOLOGÍA MOLECULAR   (Argentina)

^g UNIVERSITY OF SÃO PAULO   (Brazil)

^h Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT;

ARTICLE; CHAGAS DISEASE; COST; DIAGNOSTIC KIT; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DISEASE SURVEILLANCE; HUMAN; NONHUMAN; OUTCOME ASSESSMENT; PARAMEDICAL EDUCATION; PARASITE TRANSMISSION; POINT OF CARE TESTING; SAMPLING; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SKILL; STAFF TRAINING; TREATMENT RESPONSE; VERTICAL TRANSMISSION;

EID: 84934783199     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003697     Document Type: Article

References (35)

1. Pan American Health Organization, Chagas in the Americas for Public Health Workers; 2014. http:// www. paho. org/hq/index. php?option=com_docman&task=doc_download&Itemid=270&gid= 24717&lang=en
2. Bern C, Kjos S, Yabsley MJ, Montgomery SP. Trypanosoma cruzi and Chagas' Disease in the United States. Clin Microbiol Rev (2011) 24: 655-681. doi: 10. 1128/CMR. 00005-11 PMID: 21976603
3. Meymandi SK, Traina MI, El-Gassier A, Ngab T, Labedi M, et al. Prevalence of Chagas Disease in Los Angeles Latin American Immigrant Population with Cardiomyopathy. Journal of Cardiac Failure (2008) 14: S84.
4. Steele LS, MacPherson DW, Kim J, Keystone JS, Gushulak BD. The sero-prevalence of antibodies to trypanosoma cruzi in Latin American refugees and immigrants to Canada. J Immigr Minor Health (2007) 9: 43-47. PMID: 17006766
5. Frank M, Hegenscheid B, Janitschke K, Weinke T. Prevalence and epidemiological significance of Trypanosoma cruzi infection among Latin American immigrants in Berlin, Germany. Infection (1997) 25: 355-358. PMID: 9427054
6. Angheben A AM, Gobbi F, Marocco S, Monteiro G, Buonfrate D, Tais S, Talamo M, Zavarise G, Strohmeyer M, Bartalesi F, Mantella A, Di Tommaso M, Aiello KH, Veneruso G, Graziani G, Ferrari MM, Spreafico I, Bonifacio E, Gaiera G, Lanzafame M, Mascarello M, Cancrini G, Albajar-Viñas P, Bisoffi Z, Bartoloni A. (2011) Chagas disease in Italy: breaking an epidemiological silence. Euro Surveill 16: 19969. PMID: 21944554
7. Munoz J, Portus M, Corachan M, Fumado V, Gascon J. Congenital Trypanosoma cruzi infection in a non-endemic area. Trans R Soc Trop Med Hyg (2007) 101: 1161-1162. PMID: 17655897
8. Piron M, Verges M, Munoz J, Casamitjana N, Sanz S, et al. Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain). Transfusion (2008) 48: 1862-1868. doi: 10. 1111/j. 1537-2995. 2008. 01789. x PMID: 18522707
9. Jackson Y, Myers C, Diana A, Marti HP, Wolff H, et al. Congenital transmission of Chagas disease in Latin American immigrants in Switzerland. Emerg Infect Dis (2009) 15: 601-603. doi: 10. 3201/ eid1504. 080438 PMID: 19331743
10. Martinez de Tejada B, Jackson Y, Paccolat C, Irion O. Congenital Chagas disease in Geneva: diagnostic and clinical aspects. Rev Med Suisse (2009) 5: 2091-2092, 2094-2096. PMID: 19947451
11. Brutus L, Santalla JA, Salas NA, Schneider D, Chippaux JP. Screening for congenital infection by Trypanosoma cruzi in France. Bull Soc Pathol Exot (2009) 102: 300-309. PMID: 20131424
12. Gascon J, Bern C, Pinazo MJ. Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop (2010) 115: 22-27. doi: 10. 1016/j. actatropica. 2009. 07. 019 PMID: 19646412
13. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis (2001) 1: 92-100. PMID: 11871482
14. Ferreira MS, Borges AS (2002) Some aspects of protozoan infections in immunocompromised patients- a review. Mem Inst Oswaldo Cruz 97: 443-457. PMID: 12118272
15. World Health Organization. Chagas disease (American trypanosomiasis) fact sheet (revised in June 2010). Weekly Epidem Rec 85: 334-336.
16. World Health Organization. Research Priorities for Chagas Disease, Human African Trypanosomiasis, and Leishmaniasis. (2012) Geneva, Switzerland.
17. Reithinger R, Tarleton RL, Urbina JA, Kitron U, Gurtler RE Eliminating Chagas disease: challenges and a roadmap. BMJ (2009) 338: b1283. doi: 10. 1136/bmj. b1283 PMID: 19366739
18. Fabbro DL, Danesi E, Olivera V, Codebo MO, Denner S, et al. Trypanocide treatment of women infected with Trypanosoma cruzi and its effect on preventing congenital Chagas. PLoS Negl Trop Dis (2014) 8: e3312. doi: 10. 1371/journal. pntd. 0003312 PMID: 25411847
19. Rassi A Jr., Rassi A, Marin-Neto JÁ. Chagas disease. Lancet (2010) 375: 1388-1402. doi: 10. 1016/ S0140-6736(10)60061-X PMID: 20399979
20. Médecins Sans Frontières International meeting: new diagnostic tests are urgently needed to treat patients with Chagas disease. Rev Soc Bras Med Trop (2008) 41: 315-319. PMID: 18719818
21. Lescure FX, Le Loup G, Freilij H, Develoux M, Paris L, et al. Chagas disease: changes in knowledge and management. Lancet Infect Dis (2010) 10: 556-570. doi: 10. 1016/S1473-3099(10)70098-0 PMID: 20670903
22. Peeling RW and Mabey D. Point-of-care tests for diagnosing infections in the developing world, " Clinical Microbiology and Infection (2010), vol. 16, no. 8, pp. 1062-1069 doi: 10. 1111/j. 1469-0691. 2010. 03279. x PMID: 20670288
23. Pinazo MJ, Thomas MC, Bua J, Perrone A, Schijman AG, et al. Biological markers for evaluating therapeutic efficacy in Chagas disease, a systematic review. Expert Rev Anti Infect Ther (2014) 12: 479-496. doi: 10. 1586/14787210. 2014. 899150 PMID: 24621252
24. Viotti R, Alarcon de Noya B, Araujo-Jorge T, Grijalva MJ, Guhl F, et al. Towards a paradigm shift in the treatment of chronic Chagas disease. Antimicrob Agents Chemother (2014) 58: 635-639. doi: 10. 1128/AAC. 01662-13 PMID: 24247135
25. Duffy T, Cura CI, Ramirez JC, Abate T, Cayo NM, et al. Analytical performance of a multiplex Real- Time PCR assay using TaqMan probes for quantification of Trypanosoma cruzi satellite DNA in blood samples. PLoS Negl Trop Dis (2013) 7: e2000. doi: 10. 1371/journal. pntd. 0002000 PMID: 23350002
26. Burd EM. Validation of laboratory-developed molecular assays for infectious diseases. Clin Microbiol Rev (2010) 3: 550-576 doi: 10. 1128/CMR. 00074-09 PMID: 20610823
27. Thekisoe OM, Rodriguez CV, Rivas F, Coronel-Servian AM, Fukumoto S, et al. Detection of Trypanosoma cruzi and T. rangeli infections from Rhodnius pallescens bugs by loop-mediated isothermal amplification (LAMP). Am J Trop Med Hyg (2010) 82: 855-860. doi: 10. 4269/ajtmh. 2010. 09-0533 PMID: 20439966
28. Dorn PL, Flores J, Brahney B, Gutierrez A, Rosales R, et al. Comparison of polymerase chain reaction on fresh tissue samples and fecal drops on filter paper for detection of Trypanosoma cruzi in Rhodnius prolixus. Mem Inst Oswaldo Cruz (2001) 96: 503-505. PMID: 11391422
29. Braz LM, Raiz Junior R, Alarcon RS, Gakiya E, Amato-Neto V, et al. Suitability of a rapid DNA isolation and amplification for detection of Trypanosoma cruzi in Triatoma infestans dry fecal spots collected on filter paper. Parasite (2008) 15: 595-598. PMID: 19202767
30. Frade AF, Luquetti AO, Prata A, Ferreira AW. Western blotting method (TESAcruzi) as a supplemental test for confirming the presence of anti-Trypanosoma cruzi antibodies in finger prick blood samples from children aged 0-5 years in Brazil. Acta Trop (2011) 117: 10-13. doi: 10. 1016/j. actatropica. 2010. 08. 018 PMID: 20858452
31. Castro-Sesquen YE, Gilman RH, Galdos-Cardenas G, Ferrufino L, Sanchez G, et al. Use of a novel chagas urine nanoparticle test (chunap) for diagnosis of congenital chagas disease. PLoS Negl Trop Dis (2014) 8: e3211. doi: 10. 1371/journal. pntd. 0003211 PMID: 25275534
32. Njiru ZK. Rapid and sensitive detection of human African trypanosomiasis by loop-mediated isothermal amplification combined with a lateral-flow dipstick. Diagn Microbiol Infect Dis (2011) 69: 205-209. doi: 10. 1016/j. diagmicrobio. 2010. 08. 026 PMID: 21251567
33. Wastling SL, Picozzi K, Kakembo AS, Welburn SC. LAMP for human African trypanosomiasis: a comparative study of detection formats. PLoS Negl Trop Dis (2010) 4: e865. doi: 10. 1371/journal. pntd. 0000865 PMID: 21072228
34. Matos CS, Coelho-Dos-Reis JG, Rassi A, Luquetti AO, Dias JC, et al. Applicability of an optimized nonconventional flow cytometry method to detect anti-Trypanosoma cruzi immunoglobulin G for the serological diagnosis and cure assessment following chemotherapeutic treatment of Chagas disease. J Immunol Methods (2011) 369: 22-32. doi: 10. 1016/j. jim. 2011. 03. 007 PMID: 21477591
35. Alessio GD, Cortes DF, Machado de Assis GF, Junior PA, Ferro EA, et al. Innovations in diagnosis and post-therapeutic monitoring of Chagas disease: Simultaneous flow cytometric detection of IgG1 antibodies anti-live amastigote, anti-live trypomastigote, and anti-fixed epimastigote forms of Trypanosoma cruzi. J Immunol Methods (2014) 413: 32-44. doi: 10. 1016/j. jim. 2014. 07. 005 PMID: 25064148